


Chemical Proteomic Approaches to Study Pharmacological Landscapes of T Cells

Engineering MS2 Bacteriophage Virus-Like Particle for Targeted Drug Delivery Applications And Elucidating the Ligandability of Cancer Acquired Cysteines

From phenotypic screens to therapeutic targets for myelin repair and immunomodulation

Harnessing DCAF16 for Targeted Degradation of Nuclear-Restricted Proteins in Cancer
